Xian Gu

Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Commentary regarding"Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study".

Commentary regarding"Electroacupuncture combined with fruquintinib and sintilimab in microsatellite-stable metastatic colorectal cancer: A phase II study".

Journal: Cancer letters

Published: May 25, 2026

Comment on Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.

Comment on Lung immune prognostic index is associated with clinical outcomes in recurrent or metastatic (R/M) nasopharyngeal carcinoma receiving immunotherapy: Results from the multicenter, single-arm, phase 2 study.

Journal: Oral oncology

Published: August 19, 2025

Letter to the Editor: Advancing deep learning-based segmentation for multiple lung cancer lesions in real-world multicenter CT scans.

Letter to the Editor: Advancing deep learning-based segmentation for multiple lung cancer lesions in real-world multicenter CT scans.

Journal: European radiology experimental

Published: August 19, 2025

Comment on "Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study".

Comment on "Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study".

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: July 28, 2024

Comment on "Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis".

Comment on "Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis".

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 26, 2024

To study the mechanism of Scutellariae Radix and Astragaloside in the treatment of lung cancer based on network pharmacology.

To study the mechanism of Scutellariae Radix and Astragaloside in the treatment of lung cancer based on network pharmacology.

Journal: Medicine

Published: July 01, 2022

Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p.

Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p.

Journal: Frontiers in oncology

Published: November 18, 2020

Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression.

Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression.

Journal: OncoTargets and therapy

Published: April 10, 2013

Showing 1-8 of 8

Last Updated: 09/26/2026